Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-08-18 18:47:25
Reporting Period:
Filing Date:
Accepted Time:
2016-08-18 18:47:25
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681397 Monte Montgomery C/o Relypsa, Inc.
100 Cardinal Way
Redwood City CA 94063
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-08-16 510 $31.92 12,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Represents shares automatically sold pursuant to the applicable Restricted Stock Unit Award Agreement to satisfy tax withholding obligations in connection with the vesting of Restricted Stock Units and delivery of shares.
  2. Includes 11,000 Restricted Stock Units.